Bicarbonate

Bicarbonate

SCHEMBL9044672

O=C([O-])O.[K+].[LiH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL12615227 0.95
Bicarbonate SCHEMBL2558186 0.94 CA4 (0.60)
Bicarbonate SCHEMBL27562247 0.94 CA4 (0.60)
Bicarbonate SCHEMBL27889751 0.94
Bicarbonate SCHEMBL2420 0.94
Bicarbonate SCHEMBL1332437 0.94
Bicarbonate SCHEMBL25332008 0.89 CA4 (0.55)
Bicarbonate SCHEMBL9247678 0.89 CA1 (0.56)
Bicarbonate SCHEMBL16341497 0.89
Bicarbonate SCHEMBL2945248 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3419974-B1 PROCESS FOR THE SEPARATION OF ENANTIOMERS OF PIPERAZINE DERIVATIVES ASCENEURON SA (CH) 2021-05-05 EP disclosed
US-10344021-B2 Process for the separation of enantiomers of piperazine derivatives ASCENEURON S A (CH) 2019-07-09 US disclosed
EP-3419974-A1 PROCESS FOR THE SEPARATION OF ENANTIOMERS OF PIPERAZINE DERIVATIVES Asceneuron SA (CH) 2019-01-02 EP disclosed
WO-2017144635-A1 PROCESS FOR THE SEPARATION OF ENANTIOMERS OF PIPERAZINE DERIVATIVES ASCENEURON S. A. (CH) 2017-08-31 WO disclosed
US-20130172562-A1 PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE DR. REDDY'S LABORATORIES, INC. (US) 2013-07-04 US disclosed
EP-2582671-A2 PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE Dr. Reddy's Laboratories Ltd. (IN) 2013-04-24 EP disclosed
WO-2011160037-A2 PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE DR. REDDY'S LABORATORIES LTD. (IN) 2011-12-22 WO disclosed
EP-0420237-B1 Biphenylmethane derivative, the use of it and pharmacological compositions containing same EISAI CO LTD (JP) 1996-03-06 EP disclosed
US-5093366-A Alpha-reductase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1992-03-03 US disclosed
US-5037852-A Treating or reverting hair loss, acne or prostatic hypertrophy ONO PHARMACEUTICAL CO., LTD. (JP) 1991-08-06 US disclosed
EP-0420237-A1 Biphenylmethane derivative, the use of it and pharmacological compositions containing same Eisai Co., Ltd. (JP) 1991-04-03 EP disclosed
US-4863963-A 5-A-REDUCTASE INHIBITOR ONO PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
EP-0302423-A2 1-Phenyl-3-(1-piperazinyl)-1h-indazoles, a process and intermediates for their preparation, and the use thereof as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-02-08 EP disclosed